HEMATOPOIETIC GROWTH-FACTORS AND CHEMOPROTECTANTS - SHOULD WE MOVE TOWARD A 2-STEP PROCESS FOR PHASE-I CLINICAL-TRIALS IN ONCOLOGY

被引:1
作者
MERROUCHE, Y
CATIMEL, G
CLAVEL, M
机构
[1] Medical Oncology Department Centre Léon Bérard, Lyon
关键词
CHEMOPROTECTANTS; HEMATOPOIETIC GROWTH FACTORS; MAXIMUM TOLERATED DOSE; PHASE-I CLINICAL TRIAL;
D O I
10.1093/oxfordjournals.annonc.a058555
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:471 / 474
页数:4
相关论文
共 22 条
[1]   MODIFICATION OF CISPLATIN TOXICITY WITH DIETHYLDITHIOCARBAMATE [J].
BERRY, JM ;
JACOBS, C ;
SIKIC, B ;
HALSEY, J ;
BORCH, RF .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1585-1590
[2]   THE USE OF GRANULOCYTE COLONY-STIMULATING FACTOR TO INCREASE THE INTENSITY OF TREATMENT WITH DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST AND OVARIAN-CANCER [J].
BRONCHUD, MH ;
HOWELL, A ;
CROWTHER, D ;
HOPWOOD, P ;
SOUZA, L ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1989, 60 (01) :121-125
[3]  
BUDD GT, 1991, P AM SOC CLIN ONCOL, V10, P333
[4]  
CAVALLI F, 1990, ANN ONCOL, V1, P164
[5]  
DECKER MW, 1992, ANN ONCOL S, V1, P437
[6]   RESPONSES AND TOXIC DEATHS IN PHASE-I CLINICAL-TRIALS [J].
DECOSTER, G ;
STEIN, G ;
HOLDENER, EE .
ANNALS OF ONCOLOGY, 1990, 1 (03) :175-181
[7]  
DORR RT, 1991, SEMIN ONCOL, V18, P48
[8]   EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON MYELOSUPPRESSION INDUCED BY MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH ADVANCED BREAST-CANCER [J].
HOEKMAN, K ;
WAGSTAFF, J ;
VANGROENINGEN, CJ ;
VERMORKEN, JB ;
BOVEN, E ;
PINEDO, HM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (21) :1546-1553
[9]  
HUININK WWT, 1991, PATHOL BIOL, V39, P962
[10]   HEMATOPOIETINS - BIOLOGY, PATHOPHYSIOLOGY, AND POTENTIAL AS THERAPEUTIC AGENTS [J].
MERTELSMANN, R .
ANNALS OF ONCOLOGY, 1991, 2 (04) :251-263